Actavis
Watson buys women’s health specialists
January 23, 2013Research and Development, Sales and Marketing Actavis, Uteron, Watson, women
Watson has completed the acquisition of Uteron Pharma, a Belgium R&D-based firm specialising in women’s health products. The world’s third-largest …
Watson buys Actavis to create generics giant
April 27, 2012Sales and Marketing Actavis, Watson, generics
Watson Pharmaceuticals is to buy rival Actavis Group in a move that will create the third largest generics manufacturer in …
Actavis buys packager to boost manufacturing efficiencies
December 6, 2011Manufacturing and Production Actavis, pharmapack
Generic drugmaker Actavis has acquired Netherlands-based company PharmaPack International in a bid to cut its lead times for packaging and …
Actavis plans ‘major’ sales expansion in Latin America
October 6, 2011Sales and Marketing Actavis, emerging markets, generics
Swiss company Actavis has launched a new business unit to target the fast-growing Latin American generics market. Mirroring the branded …
Pharma manufacturing news in brief
September 21, 2010Manufacturing and Production AAIPharma, Actavis, Japan, KV Pharmaceutical, Purac, Takeda, contract manufacturing
This week’s round-up of pharmaceutical manufacturing news includes updates from Takeda, KV Pharmaceutical, Actavis, AAIPharma and Purac, while Japan’s CMOs …
Actavis appoints Dr Claudio Albrecht
June 28, 2010Sales and Marketing Actavis, appointment, sales and marketing
Icelandic generics company Actavis has appointed Dr Claudio Albrecht as its new chief executive. He formerly led Ratiopharm and has …
Actavis looks internally and externally for growth
February 10, 2010Manufacturing and Production Actavis, generics
Actavis is planning to increase the size of its manufacturing site in Iceland in order to boost output to around …
Actavis agrees deal with FDA on manufacturing problems
January 9, 2009Manufacturing and Production Actavis
Generic drug manufacturer Actavis will continue the lockdown of its New Jersey manufacturing facilities that breached quality standards, but hopes …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
